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• Supplementary Figure 4.29 (d, J = 7.9 Hz, 1H), 3.97 (ddd, J = 11.4, 4.9, 4.9 Hz, 1H), 3.83 (t, J = 9.6 Hz, 2H), 3.80-3.78 (m, 2H), 3.77 -3.65 (m, 5H), 3.58 (dd, J = 10.5, 1.9 Hz, 1H), 3.56 -3.48 (m, 6H), 3.46 (dd, J = 10.4, 3.7 Hz, 1H), 3.42 (d, J = 9.1 Hz, 1H), 3.39 (dd, J = 10.0, 7.8 Hz, 1H), 3.26 (t, J = 8.6 Hz, 1H), 3.08 (t, J = 5.1 Hz, 2H), 2.57 (dd, J = 12.5, 4.7 Hz, 1H), 1.89 (s, 3H), 1.60 (t, J = 12.2 Hz, 1H). 13 C NMR (151 MHz, D 2 O) δ 175. 68, 174.25, 103.93, 102.61, 101.04, 80.21, 75.42, 75.23, 74.51, 73.43, 73.29, 73.13, 72.58, 71.54, 69.28, 69.15, 69.14, 67.20, 64.42, 63.40, 60.89, 52.54, 40.86, 40.26, 22.83 .
Synthesis of Compound 2-
Compound I (15 mg, 20.3 µmol, 1 eq.) was dissolved in H 2 O (200 µl) to which a solution of ethynylcyclohexane (5.5 mg, 50.7 µmol, 2.5 eq.) in DMF (100 µl) was added. In a separate vial, TTTA (6.8 mg, 16.2 µmol, 0.8 eq.) , CuI (1.5 mg, 8.1 µmol, 0.4 eq.) , and DMF (200 µl) were stirred until a homogenous solution was obtained (~15 minutes). The CuI/TTTA solution (100 µl) was added to azide/alkyne mixture, and the reaction was allowed to proceed overnight at room temperature.
The reaction was centrifuged to remove insoluble precipitate and then loaded onto a P-2 column (0.625 x 42.5 cm) running in 100 mM NH 4 CO 3 . Fractions containing the product were pooled, lyophilized, redissolved in H 2 O and further purified by C18 column chromatography (2g, Waters) washing with H 2 O (20 mL) and eluting with 35% MeOH (20 mL). After evaporation and lyophilization 14.6 mg of a white solid was obtained (14.7 mg, 17.3 µmol, 85% yield). 3.87 -3.72 (m, 7H), 3.70 -3.65 (m, 3H), 3.60 -3.48 (m, 6H), 3.46 (dd, J = 10.4, 3.4 Hz, 1H), 3.43 (d, J = 9.1 Hz, 1H), 3.39 (dd, J = 10.0, 7.9 Hz, 1H), 3.26 (t, J = 8.3 Hz, 1H), 3.11 (br s, 2H), 2.62 (br s, 1H), 2.58 (dd, J = 12.4, 4.7 Hz, 1H), 1.89 -1.80 (m, 2H), 1.67 -1.53 (m, 4H), 1.32 -1.22 (m, 4H), 1.16 -1.08 (m, 1H) .
Supplementary Scheme 2 -Conditions and Reagents: i) CuI, TTTA, DMF, H 2 O. Yield: 85%.
S4
13 C NMR (151 MHz, D 2 O) δ 177. 47, 174.21, 169.40, 124.08, 103.93, 102.60, 101.07, 80.25, 75.41, 75.22, 74.53, 73.42, 73.13, 73.02, 72.60, 71.53, 69.28, 69.13, 69.09, 64.47, 63.39, 60.88, 52.83, 52.77, 40.88, 35.24, 33.12 (2C's), 26.33 (2C's) 74, 174.18, 159.25, 137.28, 129.57 (3C's), 129.16, 128.49, 104.00, 102.96, 101.16, 80.33, 75.34, 75.31, 74.45, 73.49 , 73.09, 73.06, 71.55, 71.11, 69.77, 69.32, 68.98, 68.95, 67.72 , 64.46 , 60.94 , 52.47 , 43.09 , 41.26 , 40.87 , 22 .83 .
Compound C (5 mg, 6.0 µmol, 1 eq.) was dissolved in MeOH (1 mL) and NEt 3 was added (2 drops) and the solution was cooled to 0 °C. The appropriate acyl chloride (12.0 µmol, 2 eq.) dissolved in CH 2 Cl 2 (0.5 mL) was then added dropwise and the reaction was stirred for 30 min at 0°C before being allowed to warm to room temperature. For the majority of reactions, this procedure resulted in the complete conversion. If a reaction was not complete, it was cooled back to 0 °C and additional acyl chloride was added until complete conversion was observed by TLC. In case of overacylation, a few drops of NaOMe (2M in MeOH) were added and the reaction was left to stir for 1 hr at room temperature. After this the solvents were evaporated to dryness, the residue resuspended in 100 mM NH 4 CO 3 (0.5 mL), and loaded directly onto a P-2 column (0.625 x 42.5 cm) running in 100 mM NH 4 CO 3 to yield the Cbz protected intermediates.
The intermediate was then dissolved in H 2 O (2 mL) and Pd/C (2.5 mg) was added. The flask was purged with H 2 and the reaction allowed to proceed under a H 2 atmosphere until complete (~2 hrs). After this time the reaction was filtered through a 0.22 µm syringe filter and lyophilized. Yields of 90-99% over 2 steps were typically achieved with this method and with purity typically >95%. Selected NMR characterization and spectra are given below. 62, 174.24, 172.10, 134.44, 132.88, 129.55 (2C's), 127.91 (2C's), 103.95, 102.61, 101.12, 80.30, 75.41, 75.26, 74.56, 73.41, 73.18, 73.12, 71.51, 70.89, 69.33, 69.10, 67.41, 64.58, 60.92, 52.55, 43.57, 40.88, 40.29, 22 .80. 103.97, 102.58, 101.16, 80.31, 75.39, 75.28, 74.54, 73.34, 73.32, 73.13, 71.50, 71.14, 70.89, 69.30, 69.10, 67.45, 64.55, 60.93, 52.56, 43.76, 40.89, 40.25, 22 .83. 62, 174.25, 172.15, 139.81, 134.45, 133.52, 129.49, 128.40, 124.93, 103.96, 102.65, 101.14, 80.33, 75.41, 75.28, 74.55, 73.42, 73.19, 73.13, 71.52, 70.89, 70.88, 69.32 Compound 12: 3.97 -3.95 (ddd, J = 3.5, 7.3, 9 .0 Hz, 1H), 3.91 (ddd, J = 11.5, 5.0, 5.0 Hz, 1H), 3.84 (dd, J = 10.2, 8.6 Hz, 1H), 4H), 3H), 3.60 (dd, J = 12.3, 5.3 Hz, 1H), 5H), 2H), 2H), 3.19 (dd, J = 9.1, 8.1 Hz, 1H), 3.04 (t, J = 5.0 Hz, 2H), 2.57 (dd, J = 12.3, 4.5 Hz, 1H), 1.84 (s, 3H), 1.60 (t, J = 12.2 Hz, 1H). 63, 174.24, 171.64, 141.68, 140.39, 135.08, 131.21, 130.22, 130.00 (2C's), 128.90, 127.81 (2C's), 126.99, 126.36, 103.94, 102.56, 101.14, 80.29, 75.37, 75.25, 74.56, 73.34, 73.21, 73.13, 71.49, 71.09, 70.88, 69.32, 69.10, 67.14, 64.60, 60.90, 52.56, 43.75, 40.87, 40.23, 22 .80. 102.62, 101.15, 80.33, 75.41, 75.27, 74.57, 73.39, 73.19, 73.14, 71.52, 70.88, 70.87, 69.33, 69.08, 67.70, 64.59, 60.94, 52.56, 43.52, 40.88, 40.33, 22 .79 (2C's), 21.08. (4.4 mg, 6 .0 µmol, 1 eq.) was dissolved in MeOH (1 mL) and NEt 3 was added (2 drops) and the solution was cooled to 0 °C. The appropriate acyl chloride (12.0 µmol, 2 eq.) dissolved in CH 2 Cl 2 (0.5 mL) was then added dropwise and the reaction was stirred for 30 min at 0 °C before being warmed to room temperature. Usually, this procedure resulted in the complete conversion. If a reaction was not complete, it was cooled back to 0 °C and additional acid chloride was added until complete conversion was observed by TLC. In the case of overacylation, a few drops of NaOMe (2M in MeOH) were added and the reaction was left to stir for 1 hr at room temperature. After this the reactions were evaporated to dryness, resuspended in 100 mM NH 4 CO 3 (0.5 mL), and loaded directly onto a P-2 column (0.625 x 42.5 cm) running in 100 mM NH 4 CO 3 to yield the azide protected intermediates.
S5
HRMS:13 C NMR (151 MHz, D 2 O) δ 175.
Synthesis of Compounds 9-10 -
The azide intermediate was then redissolved in THF:H 2 O (1 mL, 1:1 v/v) to which a 1M solution of PMe 3 in THF was added (15 µL, 15 µmol, 2.5 eq.). After stirring for 2 hrs at room temperature the reaction was complete and the solution was evaporated. The desired products were then purified on a C18 column eluting in 30-40% MeOH in H 2 O and obtained in ~75% yield over 2 steps.
Synthesis of Compounds 17-19, 21 -
Compound C (5 mg, 6.0 µmol, 1 eq.) was dissolved in 100 mM NaHCO 3 (0.5 mL) and the solution was cooled to 0 °C. The appropriate NHS-Ester (12.0 µmol, 2 eq.), dissolved in DMF (0.5 mL), was added dropwise to the reaction which was then left to stir at 0°C and slowly warmed to room temperature. Once the reaction was complete, it was evaporated to dryness, redissolved in H 2 O (0.5 mL), centrifuged to remove insoluble precipitate, and loaded onto a C18 column. After washing with H 2 O, the desired compound was eluted with 30-40% MeOH/H 2 O.
The Cbz protected intermediates were then subjected to hydrogenation as above, Pd/C removed by syringe filtration, and the desired products were obtained in good yield (typically >90%, with the exception of a 77% yield for the 3,5-dimethyl-4-hydroxy derivative) and excellent purity (>95%). 47, 175.60, 174.25, 171.72, 128.47 (2C's), 126.79 (2C's), 121.30, 103.97, 102.61, 101.19, 80.35, 75.38, 75.27, 74.52, 73.33, 73.32, 73.16, 71.54 , 71.02, 70.98, 69.28, 69.10, 67.69, 64.53, 60.98, 52.54, 43.51, 40.90, 40.32, 22.78, 17.40 (2C's) .
Synthesis of Compound 20 -The acylation step was carried out as described above for compounds 17-19, 21, and the product was purified on a C18 column. The azide intermediate was then reduced with PMe 3 as above for compounds 9-10 (leaving the NO 2 group intact) and purified on Biogel P-2 (0.625 x 42.5 cm) running in 100 mM NH 4 CO 3 . The desired product was obtained in this way in good yield (72%). 59, 137.88, 115.13, 94.45, 72.87, 70.04, 67.90, 61.67, 54.48, 35.68, 30 .39.
Supplementary Scheme 3 -Conditions
Compound J (2.2 g, 8.4 mmol, 1 eq) was dissolved in pyridine (40 mL) and cooled to 0 °C. Tosyl chloride (2.4 g, 12.6 mmol, 1.5 eq) dissolved in pyridine (10 mL) was then added to the flask dropwise over 5 minutes. The reaction was left to proceed for 2 hrs at 0 °C after which time another portion of tosyl chloride (1 g, 5.2 mmol, 0.6 eq) was added and the reaction was left to proceed another 1 hr at 0 °C. A final portion of tosyl chloride was added (0.2 g, 0.43 mmol, .05 eq) at 0 °C, the reaction was left to warm to room temperature and then methanol was added (20 mL). The reaction mixture was adsorbed on silica gel and eluted with 4% MeOH in EtOAc to yield the product (2.65 g, 6.4 mmol, 76% yield), compound K, as an oil. 19, 70.72, 70.69, 69.55, 67.95, 54.51, 35.53, 30.40, 21 .02.
Compound K (1.86 g, 4.5 mmol, 1 eq.) and NaN 3 (871 mg, 13.4 mmol, 3 eq.) were dissolved in DMF (20 mL) and the reaction was heated at 65 °C overnight. The mixture was then evaporated and purified on silica gel eluting with 1.5% MeOH in EtOAc. The desired product was inseparable from a by-product (believed to be the 1,6 anhydro elimination product). After evaporation 945 mg of a sticky off-white solid, compound E, was obtained. 1 H NMR the approximately 2:1 (mol:mol) ratio or product:byproduct, yielding 632 mg (2.21 mmol, 49% yield) of the desired product which was used without further purification. 129.16, 128.49, 116.55, 103.97, 102.95, 101.09, 80.31, 75.38, 75.30, 74.46, 73.49, 73.14, 73.13, 71.54, 71.10, 69.89, 69.74, 69.26, 68.87, 67.72, 64.31, 60.99, 60.08, 53.91, 52.50, 41.27, 41.00, 35.98, 30.15 .
Compound F (109 mg, 124.5 µmol, 1 eq.) was dissolved in H 2 O (5 mL, titrated to pH 1.0 with HCl). I 2 (94.8 mg, 373 µmol, 3 eq.) dissolved in 3 mL of MeOH was added and the reaction was left to proceed for 3 hrs at room temperature. The MeOH was then removed on a rotary evaporator (without heating) and the residual aqueous layer was then loaded directly onto a C18 column (2g, Waters Corp.). The column was washed with H 2 O (15 mL), 30% MeOH (20 mL), 32.5% MeOH (20 mL), and 35% MeOH (20 mL). The desired product elutes cleanly throughout the 30% MeOH elution and the early fractions of 32.5% MeOH elution after which time it coelutes with a byproduct. From this initial purification 48 mg of pure product, compound G, and 57 mg of a mixture were obtained. The mixture is then repurified as above to afford another 26 mg of pure product (74 mg total, 93.4 µmol, 75% yield). 86, 159.25, 137.28, 129.57 (3C's), 129.17, 128.50, 104.05, 102.95, 101.02, 80.55, 75.32, 75.26, 74.54, 73.50, 73.09, 72.25, 71.47, 70.98, 69.78, 69.56, 69.28, 67.93, 67.72, 64.64, 60.94, 53.72, 53.03, 41.27, 40 .98. 153.5, 120.9, 61.8, 50.4, 34.9, 32.6, 25.8, 25.7, 13.7 .
Note

Synthesis of Compound H -
Ethyl 2-(4-cyclohexyl-1H-1,2,3-triazol-1-yl)acetate (400 mg, 1.69 mmol) was suspended in a 1M aqueous NaOH solution (3 mL, 1.8 eq.) and H 2 O (8 mL) and stirred until a clear solution was obtained (~3 hrs). The mixture was neutralized with 2M HCl (3 mL) and the product was extracted with EtOAc (3 x 25 mL). The combined EtOAc extracts were dried (Na 2 SO 4 ) and concentrated to afford 350 mg of 2-(4-cyclohexyl-1H-1,2,3-triazol-1-yl)acetic acid as an off white solid (99% yield). 
S10
13 C NMR (101 MHz, MeOD) 168.53, 153.14, 121.98, 50.16 , 35.08, 32.66 (2C's), 25.83 (2C's), 2, acetic acid (50 mg, 238.9 µmol, 1 eq.) and N-hydroxysuccinimide (34.3 mg, 298.7 µmol, 1.25 eq.) were dissolved in EtOAc (2 mL) and cooled to 0 °C. DCC (61.7 mg, 298.7 µmol, 1.25 eq.) was then added and the reaction was left to proceed overnight at 0 °C. The next day the DCU was filtered off and the solvents were evaporated to dryness. The crude solid containing the NHS-Ester was used without further purification.
Compound G (16 mg, 20.2 µmol, 1 eq.) was dissolved in DMF (1 mL) and NEt 3 was added (3 drops). The reaction was cooled to 0 °C, and the above crude NHS-ester was then added in portions and stirred at 0 °C → RT checking by TLC every 2 hrs after each addition. If not complete, the reaction was cooled back to 0 °C and another portion was added, and the reaction was allowed to stir at 0°C → RT. This was continued until complete conversion was achieved. Due to some overacylation, a few drops of NaOMe were added at the end of the reaction, and the solution was left to stir for an hour before evaporation. The crude reaction was taken up in H 2 O (1 mL), centrifuged, and loaded onto a C18 column. The column was washed with H 2 O (20 mL), 45% MeOH (20 mL 94, 169.03, 159.00, 154.57, 137.35, 129.39 (2C s), 129.01, 128.50 (2C's), 123.87, 104.18, 103.27, 101.14, 80.56, 75.53, 75.51, 74.75, 73.79, 73.46, 72.97, 71.76, 71.50, 69.73, 69.61, 69.37, 69.13, 67.50, 64.66, 61.11, 53.04, 52.69, 43.35, 41.37, 41.28, 35.56, 33 .32 (2C's), 26.50 (2C's), 26.41
Synthesis of Compound 22 -Compound H (33.6 mg, 35.0 µmol, 1 eq.) was dissolved in 100 mM NaHCO 3 (1.5 mL) to which DMF (1.5 mL) was added. The reaction was cooled to 0 °C, the NHS ester of 4-hydroxy-3,5-dimethyl benzoic acid (13.8 mg, 52.6 µmol, 1.5 eq) was added, the reaction stirred for 2 hrs at 0 °C, and then warmed to room temperature. Due to some overacylation, a few drops of 2M NaOH were added and the reaction was left to stir at room temperature for 15 min before evaporation to dryness. The Cbz-protected intermediate was purified on a C18 column by washing with H 2 O (20 mL), 35% MeOH (20 mL), and elution with 50% MeOH. In this way, 28.4 mg was obtained (25.7 µmol, 73% yield).
The Cbz-intermediate (25.0 mg, 22.9 µmol, 1 eq.) was deprotected by hydrogenation as described above, and after syringe filtration and subsequent P-2 column purification, 20.0 mg of the title compound, 22, was obtained (20.5 µmol, 90% yield). 7.34 (s, 2H), 5.07 (d, J = 16.6 Hz, 1H), 4.97 (d, J = 16.6 Hz, 1H), 4.29 (d, J = 8.0 Hz, 1H), 4.26 (d, J = 7.9 Hz, 1H), 3.92 (dddd, J = 14.3, 9.3, 4.7, 4.7 Hz, 2H), 4H), 2H), 3.67 (dd, J = 8.1, 3.6 Hz, 1H), 3.62 (dd, J = 12.3, 5.1 Hz, 1H), 4H), 2H), 4H), 3.19 (t, J = 8.5 Hz, 1H), 2H), 2.57 (dd, J = 12.4, 4.6 Hz, 1H 22, 171.72, 169.31, 155.01, 128.5 (2C's), 126.62, 126.58, 123.72 (2C's), 103.97, 102.62, 101.20, 80.37, 75.38, 75.25, 74.53, 73.33, 73.15, 72.93, 71.53, 70.93, 70.67, 69.27, 68.90, 67.42, 64.53, 60.96, 52.92, 52.71, 43.31, 40.90, 40.28, 35.18, 33.11, 33.06, 26.34 (2C's), 26.25, 17.25 (2C's) .
Synthesis of Compound 23 -
This compound was made from compound C, in an analogous fashion as for compounds 3-4, 7-8, 11-16 described above, and obtained with a 94% yield over 2-steps. 1H), 7.38 (t, J = 7.9 Hz, 1H), 2H), 1H), 2H), 2H), 4.36 (d, J = 8.0 Hz, 1H), 4.27 (d, J = 7.9 Hz, 1H), 3.95 (ddd, J = 11.1, 4.8, 4.8 Hz, 1H), 3.91 (ddd, J = 10.4, 8.2, 3.1 Hz, 1H), 3.83 (dd, J = 7.2, 1.8 Hz, 1H), 3.81 (t, J = 4.5 Hz, 1H), 3H), 4H), 3H), 6H), 3.23 (dd, J = 9.2, 8. 62, 174.23, 171.12, 157.84, 157.11, 136.42, 131.23, 130.99 (2C's) , 125.00 , 123.04, 122.93, 119.90 (2C's), 118.13, 103.95, 102.62, 101.12, 80.31, 75.42, 75.27, 74.56, 73.41, 73.17, 73.13, 71.51, 70.88, 70.85, 69.33, 69.09, 67.54, 64.59, 60.94, 52.55, 43.60, 40.86, 40.30, 22 .81.
Synthesis of Compound 24
Synthesis of Fluoroacetic Acid NHS-Ester: In an oven dried round bottom flask, N-hydroxysuccinimide (524 mg, 4.55 mmol, 1.1 eq.) was suspended in CH 2 Cl 2 (15 mL) and NEt 3 was added (460.5 mg, 4.55 mmol, 1.1 eq).
The flask was cooled to 0 °C and fluoroacetyl chloride (400 mg, 4.14 mmol, 1.0 eq.) was added dropwise over 5 minutes under a N 2 atmosphere. The reaction was left to proceed for 1 hr on ice and then warmed to room temperature after which time the precipitate was filtered and the reaction was evaporated to dryness, affording 1.43 g of a white solid (Theoretical Yield = 733.4 mg 
Synthesis of Compound 25
Compound G (66 mg, 83.2 µmol, 1.0 eq.) was dissolved in DMF (2.2 mL) and NEt 3 was added (4 drops). The solution was cooled to 0 °C and the above crude, fluoroacetic acid NHS-ester (35.5 mg crude = 18.2 mg NHS ester, 104 µmol, 1.25 eq.) was added in portions. The reaction was left to proceed on ice for 1.5 hrs, MeOH was added (1 mL), and the solution was brought to room temperature. After evaporation to dryness, the residue was taken up in H 2 O (2-3 mL) and purified on a C18 column (2g, Waters) washing with H 2 O (20 mL) and eluting with 30% MeOH. Upon concentration and lyophilization, 52.6 mg (61.6 µmol, 74% yield) of a white solid was obtained. 3.94 (ddd, J = 9.1, 9.1, 2.9 Hz, 1H), 6H), 3.69 (dd, J = 8.4, 3.4 Hz, 1H), 3H), 7H), 4H) 35, 75.35, 75.31, 74.48, 73.50, 73.09, 72.65, 71.54, 70.99, 69.77, 69.33, 69.11, 68.79, 67.72, 64.54, 60.94, 52.09, 43.06, 41.26, 40. 
General Procedure for Synthesis of PEGylated Glycolipids for Liposomal Binding Studies.
The amine-terminated sialoside (4.0 µmol, 1.25 eq.) and NHS-PEG-Lipid (9.2 mg, 3.0 µmol, 1.0 eq.) were dissolved in CH 2 Cl 2 /DMSO (900 µl, 1:1, v/v) to which DIEA was added (50 µl). The reaction was left to proceed overnight at room temperature at which time the CH 2 Cl 2 was evaporated under reduced pressure. The reaction mixture was diluted with H 2 O (2.5 mL) and dialyzed against water (2 x 2L) using a 10,000 MWCO dialysis cassette (Pierce). After lyophilization, the glycolipid was afforded as a white solid in excellent yield (typically 90-99%). 1 H NMR analysis was done as previously described 4, 5 .
Synthesis of 6'BPC NeuAc-Biotin -Lac-HEG-Biotin (5 mg, 6 µmol, 1 eq.), BPC-NeuAc (4.4 mg, 9 µmol , 1.5 eq), and CTP (5.8 mg, 10.5 µmol, 1.75 eq.) were dissolved in Tris buffer (0.5 mL of 100 mM Tris, 20 mM MgCl 2 , pH 9.0) to which N. Meningitidis CMP-Synthetase (1.5 U) and P. Damsella α2-6 Sialyltransferase (0.15 U) were added. After 2.5 hrs at 37° C the reaction was loaded onto a C18 column (2g) and washed with H 2 O (20 mL), 25% MeOH (20 mL), 40% MeOH (20 mL), and 50% MeOH (20 mL). The desired product eluted at the end of the 40% MeOH washes and beginning of the 50% MeOH washes. After evaporation of the MeOH, the residual water was removed by lyophiization to afford 6.9 mgs of a white solid (5.2 µmol, 88% yield).
The 1 H-NMR Spectra is consistent with the structure and is given in the Appendix Supplementary Scheme 8 -Conditions and Reagents: CH 2 Cl 2 , DMSO, DIEA. Yields: 90-99%.
Supplementary Figure 2 -The α2-6 Linkage Specific Lectin SNA was used to show that all compounds were printed efficiently in order to rule out false positives. Biotinylated SNA (10 µg/ml, Vector Labs) was precomplexed with Alexa-Fluor-488 Streptavidin (2 µg/ml, Invitrogen) for 15 minutes and then serially diluted in PBS-Tween and applied to the analog array described in Figure 1 . After binding for 45 minutes at room temperature in a humidified chamber, the slides were washed by dipping three times into PBS-Tween, PBS, H 2 O, and centrifuged to dry. The results shown below are for a representative dilution where the signals are just below scanner saturation.
Supplementary Figure 4 -Full Titration Analysis for hCD22 and SNA binding to array in Figure 3. (a) This Figure includes higher (33 ng/ml) and intermediate (3. 3 ng/ml) concentrations of hCD22-Fc applied to the array shown in Figure 3 to further aid the reader in understanding our results. (b) SNA was applied to the array (as described above for Supplementary Figure 3) to show that all compounds were printed with similar efficiency.
